FLAME

NSU Retention Rates Show Positive Measures

Retrieved on: 
Wednesday, February 7, 2024
Demon, Orientation, Education, Growth, Student, College, School, Blue Shield, Mentorship, NSU, Blue, Faculty, FLAME, Student affairs, Blue Cross, Associate, The First-Year Experience Program, Enrollment, Northwestern State University, Enrollment management, Nursing

Over the past two years, NSU faculty, advisors and student-service personnel made intentional efforts to address retention through intervention, engagement and mentoring.

Key Points: 
  • Over the past two years, NSU faculty, advisors and student-service personnel made intentional efforts to address retention through intervention, engagement and mentoring.
  • "This positive data demonstrates the hard work and dedication NSU's faculty and staff in Student Affairs, Academic Affairs and all positions that support student success," said NSU President Dr. Marcus Jones.
  • A study reported that one out of 53 jobs in the region is supported by NSU and its students.
  • "Degree programs at NSU incorporate workforce skills into academic offerings to ensure that graduates are career ready," said NSU President Dr. Marcus Jones.

Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance

Retrieved on: 
Tuesday, January 9, 2024
Coronary thrombosis, Patient, Traction, Annual report, RCT, VTE, FLAME, Randomized controlled trial, Isabella Tree, Growth, Pharmaceutical industry

IRVINE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced preliminary unaudited fourth quarter and full year 2023 revenue and established its 2024 financial guidance.

Key Points: 
  • IRVINE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced preliminary unaudited fourth quarter and full year 2023 revenue and established its 2024 financial guidance.
  • Preliminary unaudited revenue for the fourth quarter of 2023 is expected to be at least $132.0 million, up approximately 22% year-over-year.
  • Preliminary unaudited revenue for the full year 2023 is expected to be at least $493.5 million, up approximately 29% over the full year 2022.
  • Further detail will be provided when Inari reports its financial results for the fourth quarter and full year 2023.

Inari Medical Reports First Quarter 2023 Financial Results

Retrieved on: 
Wednesday, May 3, 2023
FLAME, Pulmonary embolism, American College of Cardiology, Research, Organization, Inari, Patient, Investment, American College, FDA, Video game, Pharmaceutical industry, Cardiology

IRVINE, Calif., May 03, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its first quarter ended March 31, 2023.

Key Points: 
  • IRVINE, Calif., May 03, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its first quarter ended March 31, 2023.
  • Generated revenue of $116.2 million in the first quarter of 2023, up 7.8% sequentially and 33.9% over the same quarter last year.
  • “Our strong financial performance in the first quarter reflected consistent execution across all of our growth drivers,” said Drew Hykes, CEO of Inari Medical.
  • Inari Medical will host a conference call to discuss the first quarter 2023 financial results after market close on Wednesday, May 3, 2023 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System

Retrieved on: 
Monday, March 6, 2023
NYU, MD, Principal, Mitchell Silver, Mortality, Methodist Hospital, FACC, Nursing care plan, DO, PE, Patient, New York University Grossman School of Medicine, American College of Cardiology, RPVI, American College, ACC, Pharmaceutical industry, Medical imaging, FLAME, VTE

FLAME is the largest prospective study of interventional treatment in high-risk PE, a patient population with a historical mortality rate of 25-50%.

Key Points: 
  • FLAME is the largest prospective study of interventional treatment in high-risk PE, a patient population with a historical mortality rate of 25-50%.
  • The study collected data on patients treated with FlowTriever and on those treated with other therapies in a context arm.
  • The study was stopped early due to overwhelmingly positive outcomes in the FlowTriever patients.
  • Furthermore, the magnitude of the benefit seen in FLAME will undoubtably influence treatment decisions over a broader spectrum of PE patients.”

Inari Medical Announces Results from the Fully Enrolled 800-patient US Cohort of the FlowTriever FLASH Registry

Retrieved on: 
Monday, September 19, 2022
RCT, Columbia University College of Dental Medicine, UPMC, Bleeding, Columbia University, MD, FDA, Principal, PERT, Interventional cardiology, Thrombosis, Pulmonary embolism, VTE, Patient, University of Pittsburgh Medical Center, Deep vein thrombosis, CE, Columbia University Irving Medical Center, Physician, Surgeon, ICU, European Association for the Study of the Liver, TCT, NASDAQ, Associate, PE, Association, GLOBE, FLASH, Mortality, University, FLAME, Disease, Maes, Pharmaceutical industry, EuroIntervention, Medicine

The data was also simultaneously published in EuroIntervention, the official journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Key Points: 
  • The data was also simultaneously published in EuroIntervention, the official journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
  • FLASH is a prospective, multicenter, single-arm registry evaluating real-world patient outcomes after treatment of PE with FlowTriever.
  • We believe these results, in addition to the more than 35,000 patients treated commercially, reinforce FlowTriever as a front-line therapy for PE, said Thomas Tu, MD, Chief Medical Officer of Inari Medical.
  • Inari Medical, Inc. is a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases.

IEEE Computer Society Diversity & Inclusion Fund Announces Newly Approved Programs

Retrieved on: 
Wednesday, March 2, 2022
People, Navajo Technical University, IEEE Computer Society, LOS, Inclusion, AP, Data, Research, Society, Diversity, View, Woman, Student, IEEE CS, Arduino, Machine learning, Disability, Volunteering, Solution, Program, BIPOC, FLAME, Goal, Multimedia, Computer literacy, IEEE, University, Faculty, MASS, Non-governmental organization, Education, Technology, Engineering, Navajo Nation, Consumer electronics, Creative industries, Management, Medicine, Tutoring, STEM

LOS ALAMITOS, Calif., March 2, 2022 /PRNewswire/ --The IEEE Computer Society (IEEE CS) announces the top five programs that have received funding approval from the IEEE CS Diversity & Inclusion Fund .

Key Points: 
  • LOS ALAMITOS, Calif., March 2, 2022 /PRNewswire/ --The IEEE Computer Society (IEEE CS) announces the top five programs that have received funding approval from the IEEE CS Diversity & Inclusion Fund .
  • "As diversity, equity, and inclusion remain an integral component of the Computer Society's mission, the impactful projects approved under the Diversity and Inclusion Fund foster the Society's continued progress to support a more inclusive community for members and beyond," said Nita Patel, chair of the Diversity & Inclusion Committee and IEEE CS President-elect.
  • The IEEE Computer Society is the world's home for computer science, engineering, and technology.
  • Known as the premier organization that empowers the people who drive technology, the IEEE Computer Society offers international conferences, peer-reviewed publications, a unique digital library, and training programs.

AlmaLinux Delivers First HPC CentOS Replacement on Microsoft Azure

Retrieved on: 
Tuesday, December 14, 2021
Foundation, Data Management, Philanthropy, Technology, Software, Organization, Library, Linux, CentOS, Math Kernel Library, AMD, Genomics, Intel, FLAME, Microsoft, Hyperion, FFTW, MPI, Cloud computing, Open MPI, Machine learning, AlmaLinux, Microsoft Azure, Efficiency, Communication, Azure, InfiniBand, HPC, Acceleration, Video game console

The AlmaLinux OS Foundation , the nonprofit that stewards the community owned and governed open source CentOS alternative, today announced availability of the first AlmaLinux high-performance computing (HPC) image for deploying HPC workloads on Microsoft Azure.

Key Points: 
  • The AlmaLinux OS Foundation , the nonprofit that stewards the community owned and governed open source CentOS alternative, today announced availability of the first AlmaLinux high-performance computing (HPC) image for deploying HPC workloads on Microsoft Azure.
  • AlmaLinux HPC Image for Microsoft Azure was purpose-built in collaboration with Microsoft for organizations to optimally manage even the most advanced HPC workloads on the Azure cloud platform, enabling greater agility and performance optimization.
  • Those who previously relied on CentOS 8 for HPC on Azurewhich will be end of life on December 31, 2021now have a production-ready, drop-in replacement with AlmaLinux.
  • AlmaLinux HPC Image for Microsoft Azure is available immediately in the Azure Marketplace.

FireStarter Implements Blockpass KYC for Incubated Metaverse Projects

Retrieved on: 
Saturday, November 27, 2021
Blockpass, Crypto, App store, FLAME, Partnership, AML, Polygon, Compliance, Initial, Blockchain, Supreme, ID, Decentralized finance, Animoca Brands, Firestarter, Organization, PEP, Google Play, NFT, Engineering, Nike, Ecosystem, KYC, IMO, Forbes, Cryptocurrency, Online shopping

San Francisco-based FireStarter is the first Initial Metaverse Offering (IMO) launchpad on the Polygon network, incubating GameFi, Social Token, NFT and DeFi projects.

Key Points: 
  • San Francisco-based FireStarter is the first Initial Metaverse Offering (IMO) launchpad on the Polygon network, incubating GameFi, Social Token, NFT and DeFi projects.
  • FireStarter provides resources to the top metaverse projects and communities, leading to an IMO where projects open their presale funding rounds to early supporters and $FLAME Token Holders.
  • "We're delighted to be working with FireStarter as they support new projects and start-ups," said Adam Vaziri, Blockpass CEO.
  • "In working with the top metaverse projects, a certain standard is needed for a safe and compliant KYC solution.

SEVA.LOVE, a Transformational Platform for Good, is Powering NFTs and the Metaverse on the Hedera Network

Retrieved on: 
Thursday, October 28, 2021
Ethereum, Bitcoin, WorldPay, Woman, Piper, NFT, Twitter, UCL, Organization, Partnership, Dentons, Nike, Athlete, FIS, Nomura Holdings, IIT, Telegram Open Network, IBM, Firestarter, Polygon, London School of Economics, Engineering, Electronics, FLAME, Poverty, Indian Institute of Technology (BHU) Varanasi, University College London, Mental health, NFC, Non-fungible token, Discord, Institute, Education, Violence, EDF, Ecosystem, Carbon, Forbes, IMO, DLA, Avery Dennison, Blockchain, Zain Group, CEO, Project Firestart, Awareness, Deutsche Telekom, Standard Bank, Wipro, Hunger, Decentralized finance, DLA Piper, LSE, Technology, LG Electronics, HTS, DBS Bank, Visa, Supreme, Telegraphy, Shinhan Bank, Worldpay, Cryptocurrency, Toy

SEVA.LOVE will focus on value creation in the digital metaverse with wearable assets, physically redeemable artwork, and unique ownership benefits.

Key Points: 
  • SEVA.LOVE will focus on value creation in the digital metaverse with wearable assets, physically redeemable artwork, and unique ownership benefits.
  • The platform will focus on maximizing value creation to empower communities and provide the optimal and seamless technology enabled solution.
  • The SEVA.LOVE platform at its core is powered by Hedera , the greenest public ledger on the market and the world's most-used public network by total transaction count (over 1.7 billion).
  • FireStarter - ( FireStarter.Fi ) is the first Initial Metaverse Offering (or IMO) launchpad on the Polygon network that incubates and launches GameFi, Social Token, NFT and DeFi projects by way of the metaverse.

Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System in Pulmonary Embolism Patients

Retrieved on: 
Monday, October 18, 2021
PERT, Thrombosis, Division, Goal, CE marking, Death, RCT, Thomas Jefferson University, Pulmonary embolism, Risk, Bleeding, Physician, Length of stay, FLAME, Mortality, CDT, PE, VTE, FDA, Emory University Hospital, Patient, GLOBE, Â, Interventional radiology, FLASH, Randomized controlled trial, Deep vein thrombosis, NASDAQ, Radiology, Pharmaceutical industry

PEERLESS is a new randomized controlled trial (RCT) comparing the clinical outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the FlowTriever System versus catheter-directed thrombolysis (CDT).

Key Points: 
  • PEERLESS is a new randomized controlled trial (RCT) comparing the clinical outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the FlowTriever System versus catheter-directed thrombolysis (CDT).
  • The trial design was presented at the 7th Annual Pulmonary Embolism Symposium, sponsored by the PERT Consortium.
  • PEERLESS is a prospective, multi-center trial that will include up to 700 patients and 60 centers in the United States and Europe.
  • The FlowTriever system is 510(k)-cleared by FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.